NL-OMON52517
Recruiting
Not Applicable
[18F]Fluoride PET-CT imaging for detection and monitoring of bone formation in spondyloarthritis - [18F]Fluoride PET in SpA
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 48
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosis of psoriatic arthritis according to the 2006 Classification
- •Criteria for Psoriatic Arthritis (CASPAR) or ankylosing spondylitis according
- •to the ASAS criteria
- •Patients with clinically active disease as assessed by a physician;
- •o In PsA defined as clinically active disease with at least one clinically
- •active enthesitis site and a clinical indication to start with Secukinumab
- •o In AS defined as a Bath Ankylosing Spondylitis Disease Activity Index
- •(BASDAI) of 4 or higher and a clinical indication to start with Secukinumab.
- •Treatment with disease modifying anti\-rheumatic drugs (DMARDS) and
- •non\-steroidal anti\-inflammatory drugs (NSAID) is permitted, provided that there
Exclusion Criteria
- •Prior treatment with anti\-IL\-17 (for Secukinumab starters)
- •Treatment with any investigational drug within the previous 3 months.
- •Pregnancy or breast\-feeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Detection and monitoring of effects of biological therapy on bone formation in patients with Bechterew's disease or psoriatic arthritis with the use of a Positron Emission Tomography (PET) scan.Spondyloarthritis (ankylosing spondylitis and psoriatic arthritis)Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2017-004850-40-NLVU Medical Center, department of Rheumatology48
Recruiting
Not Applicable
[18F]Fluoride PET-CT imaging for detection and monitoring of bone fomration in spondyloarthritisAnkylosing spondylitis, psoriatic arthritisNL-OMON23538ovartis, Foreum, Pfizer48
Withdrawn
Not Applicable
18F-fluoride PET-scan as complementary diagnostic medium for patients with otosclerosis - A pilot studyfixation of the stapesotosclerosis1001399510027584NL-OMON36729Medisch Universitair Ziekenhuis Maastricht40
Active, not recruiting
Phase 1
Monitoring of respons to therapy in rheumatoid arthritis with the help of a PET scan.Rheumatoid ArthritisTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]EUCTR2018-004429-94-NLVU Medical Center, department of Rheumatology10
Completed
Not Applicable
[18F]fluoro-PEG-folate PET/CT imaging in patients with epithelial ovarian cancerEpithelial ovarian cancer10033283NL-OMON52813eids Universitair Medisch Centrum15